Könczöl Árpád, Engel Rita, Szabó Krisztina, Hornok Katalin, Tóth Szilvia, Béni Zoltán, Prechl Anita, Máthé Imre, Tibor Balogh György
Compound Profiling Laboratory, Gedeon Richter Plc., H-1475 Budapest, Hungary.
MTA Centre for Ecological Research, Institute of Ecology and Botany, H-2163 Vácrátót, Hungary.
J Ethnopharmacol. 2014 Aug 8;155(1):776-84. doi: 10.1016/j.jep.2014.06.020. Epub 2014 Jun 16.
Oxybaphus nyctagineus (Michx.) Sweet has traditionally been used by several Native American tribes predominantly as a topical anti-inflammatory and analgesic agent.
To evaluate the antioxidant, analgesic and anti-inflammatory activity of the extracts prepared from the aerial parts of Oxybaphus nyctagineus and to characterize the major chemical constituents of the bioactive extracts.
Crude polar and apolar extracts (PCE and ACE) of the herb of Oxybaphus nyctagineus were prepared and tested in the models of the CFA-induced hyperalgesia in rat knee and carrageenan-induced paw edema in rat. To identify the active compounds, subfractions were prepared by column chromatography and subjected in vitro assays, such as antioxidant assays (DPPH, peroxynitrite (ONOO-) scavenging), and the LPS-induced IL-1β release test in human monocytes. Preparative HPLC was employed for the isolation of active substances, while phytochemical analysis was performed by mean of LC-MS/MS and NMR.
The topically administered PCE and ACE of Oxybaphus nyctagineus demonstrated a significant analgesic and anti-inflammatory effect in the inflammation animal models. The subfraction A4 of ACE and the subfraction P5 of PCE considerably inhibited the LPS-induced IL-1β release in human monocytes, while the strongest activity was localized in the subfraction P5 in the antioxidant assays. The HPLC-MS/MS and NMR analysis revealed that 6-methoxyflavonol diglycosides, namely patuletin-3-O-robinobioside (1), 6-methoxykaempferol-3-O-robinobioside (2), spinacetin-3-O-robinobioside (3), and hydroxy-polyenoic fatty acids, namely corchorifatty acid B (4), 9-hydroxy-10E,12Z,15Z-octadecatrienoic acid (9-HOT acid) (5), and 9-hydroxy-10E,12Z-octadecadienoic acid (9-HOD acid) (6) were present in PCE, and in ACE as major compounds.
The results of this study established a pharmacological evidence for the traditional use of Oxybaphus nyctagineus as an anti-inflammatory agent used topically, and provided data on its phytochemical composition for the first time.
紫茉莉(Oxybaphus nyctagineus (Michx.) Sweet)传统上被几个美洲原住民部落主要用作局部抗炎和镇痛剂。
评估从紫茉莉地上部分制备的提取物的抗氧化、镇痛和抗炎活性,并表征生物活性提取物的主要化学成分。
制备紫茉莉草药的粗极性和非极性提取物(PCE和ACE),并在大鼠膝关节CFA诱导的痛觉过敏模型和大鼠角叉菜胶诱导的爪肿胀模型中进行测试。为了鉴定活性化合物,通过柱色谱法制备亚组分,并进行体外试验,如抗氧化试验(DPPH、过氧亚硝酸盐(ONOO-)清除),以及人单核细胞中LPS诱导的IL-1β释放试验。采用制备型HPLC分离活性物质,同时通过LC-MS/MS和NMR进行植物化学分析。
局部施用的紫茉莉PCE和ACE在炎症动物模型中表现出显著的镇痛和抗炎作用。ACE的亚组分A4和PCE的亚组分P5显著抑制人单核细胞中LPS诱导的IL-1β释放,而在抗氧化试验中最强的活性位于亚组分P5中。HPLC-MS/MS和NMR分析表明,PCE中存在6-甲氧基黄酮醇二糖苷,即牡荆素-3-O-刺槐二糖苷(1)、6-甲氧基山奈酚-3-O-刺槐二糖苷(2)、菠菜素-3-O-刺槐二糖苷(3),以及羟基多烯脂肪酸,即黄麻脂肪酸B(4)、9-羟基-10E,12Z,15Z-十八碳三烯酸(9-HOT酸)(5)和9-羟基-10E,12Z-十八碳二烯酸(9-HOD酸)(6),ACE中也以这些化合物为主要成分。
本研究结果为紫茉莉作为局部使用的抗炎剂的传统用途建立了药理学证据,并首次提供了其植物化学成分的数据。